These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9027929)

  • 1. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
    Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
    Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
    van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
    J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
    Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
    Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
    Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
    Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
    Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
    Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
    Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
    Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
    Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
    Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of changes in endogenous serotonin level by positron emission tomography with [
    Ikoma Y; Takuwa H; Nishino A; Maeda J; Kawamura K; Obata T; Zhang MR; Higuchi M; Suhara T
    Ann Nucl Med; 2021 Aug; 35(8):955-965. PubMed ID: 34101154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
    Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
    Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
    van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
    Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
    Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
    Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.